151 – 160 of 286
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complement.
(
- Contribution to journal › Article
-
Mark
Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies.
(
- Contribution to journal › Scientific review
-
Mark
Streptococcus pneumoniae endopeptidase O (PepO): a multifunctional plasminogen and fibronectin binding protein, facilitating evasion of innate immunity and invasion of host cells.
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
A functional variant in the CFI gene confers a high risk of age-related macular degeneration
(
- Contribution to journal › Article
-
Mark
Binding of complement inhibitor C4b-binding protein to a highly virulent S. pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells.
(
- Contribution to journal › Article
- 2012
-
Mark
Discovery and Structural Modification of 1-Phenyl-3-(1-phenylethyl)urea Derivatives as Inhibitors of Complement
(
- Contribution to journal › Article
-
Mark
Functional Recruitment of the Human Complement Inhibitor C4BP to Yersinia pseudotuberculosis Outer Membrane Protein Ail
(
- Contribution to journal › Article
-
Mark
Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4
(
- Contribution to journal › Article